Northern Trust’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-529,619
| Closed | -$2.73M | – | 4352 |
|
|
2019
Q2 | $2.73M | Buy |
529,619
+14,030
| +3% | +$63.1K | ﹤0.01% | 2888 |
|
|
2019
Q1 | $1.86M | Sell |
515,589
-405
| -0.1% | -$1.75K | ﹤0.01% | 3127 |
|
|
2018
Q4 | $3.16M | Buy |
515,994
+8,135
| +2% | +$49.6K | ﹤0.01% | 2789 |
|
|
2018
Q3 | $2.97M | Buy |
507,859
+18,093
| +4% | +$90.4K | ﹤0.01% | 2994 |
|
|
2018
Q2 | $2.08M | Buy |
489,766
+32,773
| +7% | +$165K | ﹤0.01% | 3189 |
|
|
2018
Q1 | $2.02M | Sell |
456,993
-2,210
| -0.5% | -$9.86K | ﹤0.01% | 3096 |
|
|
2017
Q4 | $2.42M | Sell |
459,203
-11,153
| -2% | -$68.2K | ﹤0.01% | 3034 |
|
|
2017
Q3 | $2.88M | Buy |
470,356
+6,372
| +1% | +$40.3K | ﹤0.01% | 2958 |
|
|
2017
Q2 | $3.35M | Buy |
463,984
+43,967
| +10% | +$270K | ﹤0.01% | 2859 |
|
|
2017
Q1 | $2.23M | Buy |
420,017
+481
| +0.1% | +$3.25K | ﹤0.01% | 3028 |
|
|
2016
Q4 | $3.01M | Buy |
419,536
+46,681
| +13% | +$377K | ﹤0.01% | 2864 |
|
|
2016
Q3 | $3.49M | Buy |
372,855
+15,993
| +4% | +$133K | ﹤0.01% | 2769 |
|
|
2016
Q2 | $2.26M | Buy |
356,862
+24,445
| +7% | +$157K | ﹤0.01% | 2966 |
|
|
2016
Q1 | $1.83M | Sell |
332,417
-51,545
| -13% | -$194K | ﹤0.01% | 3039 |
|
|
2015
Q4 | $2.14M | Sell |
383,962
-68,369
| -15% | -$452K | ﹤0.01% | 3026 |
|
|
2015
Q3 | $3.83M | Buy |
452,331
+118,850
| +36% | +$2.01M | ﹤0.01% | 2614 |
|
|
2015
Q2 | $5.04M | Buy |
333,481
+17,221
| +5% | +$249K | ﹤0.01% | 2511 |
|
|
2015
Q1 | $5.06M | Buy |
316,260
+14,286
| +5% | +$254K | ﹤0.01% | 2498 |
|
|
2014
Q4 | $5.38M | Buy |
301,974
+36,210
| +14% | +$451K | ﹤0.01% | 2463 |
|
|
2014
Q3 | $2.67M | Buy |
265,764
+135,290
| +104% | +$1.64M | ﹤0.01% | 2906 |
|
|
2014
Q2 | $2.04M | Buy |
130,474
+20,207
| +18% | +$286K | ﹤0.01% | 3087 |
|
|
2014
Q1 | $2.05M | Buy |
110,267
+18,955
| +21% | +$380K | ﹤0.01% | 3126 |
|
|
2013
Q4 | $1.74M | Buy |
91,312
+67,217
| +279% | +$1.36M | ﹤0.01% | 3215 |
|
|
2013
Q3 | $393K | Buy |
+24,095
| New | +$253K | ﹤0.01% | 3496 |
|
Other funds holding PETX
Northern Trust's PETX Position: Q3 2019 in Review
Northern Trust sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 529,619 shares — an estimated $2.73M sold.
Northern Trust first reported a position in PETX in Q3 2013 and held it in 24 quarters. The position peaked at $5.38M in Q4 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Northern Trust reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Northern Trust sold 529,619 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $2.73M.
- Northern Trust first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and held it in 24 quarters.
- Northern Trust's Aratana Therapeutics, Inc. position peaked at $5.38M in Q4 2014.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Northern Trust's 13F filing for Q3 2019, filed 13 Nov 2019.